Affirm Holdings Will Partner With Visa For Its Debit Card

-Reuters

byBenzinga Newsdesk

January 27, 2022

1 minute read

-Reuters

News

Elon Musk Calls Alcohol Poison But Shares This In Common With Bill Gates

By Chris Katje

Today, 8:20 AM

A Twitter thread about eliminating alcohol consumption by entrepreneur and investor Marc Andreessen caught the attention of Elon Musk. Here’s what Musk had to say about alcohol and how Bill Gates factors into the sector.

HEINY

Edgewell Personal Care Updates FY22 Adj. EPS Guidance From $2.98-$3.26 To $2.74-$3.02 To Reflect Impact Of Billie Acquisition

By Bill Haddad

Today, 8:20 AM

Full Fiscal Year 2022 Financial Outlook The Company is updating its previously provided outlook assumptions for fiscal 2022 to include the ten month impact of the Billie acquisition and the incremental negative impact

EPC

Foxo Technologies, Effective November 14, 2022, Jon Sabes Has Been Terminated As CEO And Chairman Of Board Of Company; Appointed Tyler Danielson, As Interim CEO And Bret Barnes As Chairman Of The Board

By Benzinga Newsdesk

Today, 8:20 AM

FOXO Technologies Inc. (NYSEAM:FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science,

FOXO

HC Wainwright & Co. Reiterates Buy on Geovax Labs, Maintains $8 Price Target

By Benzinga Newsdesk

Today, 8:20 AM

HC Wainwright & Co. analyst Vernon Bernardino reiterates Geovax Labs (NASDAQ:GOVX) with a Buy and maintains $8 price target.

GOVX

Affirm Holdings Will Partner With Visa For Its Debit Card

Related Posts

Elon Musk Calls Alcohol Poison But Shares This In Common With Bill Gates

Edgewell Personal Care Updates FY22 Adj. EPS Guidance From $2.98-$3.26 To $2.74-$3.02 To Reflect Impact Of Billie Acquisition

Foxo Technologies, Effective November 14, 2022, Jon Sabes Has Been Terminated As CEO And Chairman Of Board Of Company; Appointed Tyler Danielson, As Interim CEO And Bret Barnes As Chairman Of The Board

HC Wainwright & Co. Reiterates Buy on Geovax Labs, Maintains $8 Price Target